ID   KT21-MG1-Luc5D
AC   CVCL_JK00
DR   Wikidata; Q54900571
RX   PubMed=25596744;
RX   PubMed=28469964;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Firefly luciferase.
CC   Derived from site: In situ; Brain, falx cerebri; UBERON=UBERON_0006059.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M429 ! KT21-MG1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 9
//
RX   PubMed=25596744; DOI=10.18632/oncotarget.2810; PMCID=PMC4385830;
RA   Chow H.-Y., Dong B., Duron S.G., Campbell D.A., Ong C.C.,
RA   Hoeflich K.P., Chang L.-S., Welling D.B., Yang Z.-J., Chernoff J.;
RT   "Group I Paks as therapeutic targets in NF2-deficient meningioma.";
RL   Oncotarget 6:1981-1994(2015).
//
RX   PubMed=28469964; PMCID=PMC5411799;
RA   Guo J.-M., Grovola M.R., Xie H., Coggins G.E., Duggan P., Hasan R.,
RA   Huang J.-L., Lin D.W., Song C., Witek G.M., Berritt S., Schultz D.C.,
RA   Field J.;
RT   "Comprehensive pharmacological profiling of neurofibromatosis cell
RT   lines.";
RL   Am. J. Cancer Res. 7:923-934(2017).
//